NYSE:RMED RA Medical Systems Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding RA Medical Systems Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.25 -0.01 (-3.91 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range$0.25Now: $0.25▼$0.2650-Day Range$0.25MA: $0.30▼$0.3752-Week Range$0.23Now: $0.25▼$2.69Volume1.78 million shsAverage Volume3.07 million shsMarket Capitalization$17.79 millionP/E RatioN/ADividend YieldN/ABeta1.17 ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.Read More Beat the Market (BTM) Rank™ 3.2 Analyst's Opinion Consensus RatingRA Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.50, RA Medical Systems has a forecasted upside of 511.0% from its current price of $0.25.Amount of Analyst CoverageRA Medical Systems has only been the subject of 1 research reports in the past 90 days. Previous Next 2.1 Community Rank Outperform VotesRA Medical Systems has received 81 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRA Medical Systems has received 110 “underperform” votes. (Add your “underperform” vote.)Community SentimentRA Medical Systems has received 57.59% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about RA Medical Systems and other stocks. Vote “Outperform” if you believe RMED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RMED will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRA Medical Systems does not currently pay a dividend.Dividend GrowthRA Medical Systems does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RA Medical Systems insiders have bought more of their company's stock than they have sold. Specifically, they have bought $3,500.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.40% of the stock of RA Medical Systems is held by insiders.Percentage Held by InstitutionsOnly 5.12% of the stock of RA Medical Systems is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for RA Medical Systems are expected to grow in the coming year, from ($0.78) to ($0.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RA Medical Systems is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RA Medical Systems is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRA Medical Systems has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.2Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.90 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:RMED Previous Symbol CUSIPN/A CIKN/A Webwww.ramed.com Phone760-804-1648Debt Debt-to-Equity Ratio0.17 Current Ratio4.07 Quick Ratio3.74Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.20 million Price / Sales2.47 Cash FlowN/A Price / Cash FlowN/A Book Value$2.47 per share Price / Book0.10Profitability EPS (Most Recent Fiscal Year)($4.33) Net Income$-56,960,000.00 Net Margins-807.30% Return on Equity-140.19% Return on Assets-102.78%Miscellaneous Employees95 Outstanding Shares72,468,000Market Cap$17.79 million Next Earnings Date12/4/2020 (Estimated) OptionableNot Optionable $0.25 -0.01 (-3.91 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive RMED News and Ratings via Email Sign-up to receive the latest news and ratings for RMED and its competitors with MarketBeat's FREE daily newsletter. RA Medical Systems (NYSE:RMED) Frequently Asked Questions How has RA Medical Systems' stock been impacted by COVID-19 (Coronavirus)? RA Medical Systems' stock was trading at $1.2563 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RMED shares have decreased by 80.5% and is now trading at $0.2455. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of RA Medical Systems? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RA Medical Systems in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for RA Medical Systems. When is RA Medical Systems' next earnings date? RA Medical Systems is scheduled to release its next quarterly earnings announcement on Friday, December 4th 2020. View our earnings forecast for RA Medical Systems. How were RA Medical Systems' earnings last quarter? RA Medical Systems Inc (NYSE:RMED) released its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.43) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by $0.21. RA Medical Systems had a negative net margin of 807.30% and a negative return on equity of 140.19%. View RA Medical Systems' earnings history. What price target have analysts set for RMED? 3 Wall Street analysts have issued 12-month target prices for RA Medical Systems' stock. Their forecasts range from $1.00 to $2.00. On average, they expect RA Medical Systems' stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 511.0% from the stock's current price. View analysts' price targets for RA Medical Systems. Are investors shorting RA Medical Systems? RA Medical Systems saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 2,660,000 shares, an increase of 50.3% from the August 15th total of 1,770,000 shares. Based on an average daily trading volume, of 5,960,000 shares, the days-to-cover ratio is currently 0.4 days. View RA Medical Systems' Short Interest. Who are some of RA Medical Systems' key competitors? Some companies that are related to RA Medical Systems include SANUWAVE Health (SNWV), BRAINSWAY LTD/S (BWAY), Daxor (DXR), Titan Medical (TMDI), Nephros (NEPH), Nephros (NEPH), AIT Therapeutics (AITB), STRATA Skin Sciences (SSKN), Sintx Technologies (SINT), Neovasc (NVCN), Nephros (NEPHD), Sensus Healthcare (SRTS), IsoRay (ISR), Delcath Systems (DCTH) and Delcath Systems (DCTH). View all competitors. What other stocks do shareholders of RA Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other RA Medical Systems investors own include BioNano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Novan (NOVN), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), OrganiGram (OGI), Pennsylvania R.E.I.T. (PEI), CBL & Associates Properties (CBL) and Zosano Pharma (ZSAN). Who are RA Medical Systems' key executives? RA Medical Systems' management team includes the following people: Mr. Dean Irwin, CEO, Chief Technology Officer & Chairman of Director (Age 56)Mr. Jeffrey Jay Kraws, Pres (Age 55)Ms. Melissa Burstein, Exec. VP & Director (Age 43)Mr. Richard Heymann, Director of Corp. Strategy & Bus. Devel. (Age 64)Mr. Andrew C. Jackson, Chief Financial Officer (Age 50) When did RA Medical Systems IPO? (RMED) raised $50 million in an initial public offering on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers. What is RA Medical Systems' stock symbol? RA Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED." Who are RA Medical Systems' major shareholders? RA Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Two Sigma Advisers LP (0.28%) and Bridgeway Capital Management Inc. (0.26%). Company insiders that own RA Medical Systems stock include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws, Jonathan Will Mcguire, Martin Burstein, Richard Mejia Jr and William R Enquist. View institutional ownership trends for RA Medical Systems. Which institutional investors are buying RA Medical Systems stock? RMED stock was bought by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, and Bridgeway Capital Management Inc.. Company insiders that have bought RA Medical Systems stock in the last two years include Jonathan Will Mcguire, Richard Mejia Jr, and William R Enquist. View insider buying and selling activity for RA Medical Systems. How do I buy shares of RA Medical Systems? Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is RA Medical Systems' stock price today? One share of RMED stock can currently be purchased for approximately $0.25. How big of a company is RA Medical Systems? RA Medical Systems has a market capitalization of $17.79 million and generates $7.20 million in revenue each year. The company earns $-56,960,000.00 in net income (profit) each year or ($4.33) on an earnings per share basis. RA Medical Systems employs 95 workers across the globe. What is RA Medical Systems' official website? The official website for RA Medical Systems is www.ramed.com. How can I contact RA Medical Systems? RA Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at 760-804-1648 or via email at [email protected] This page was last updated on 9/22/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
